Indian firm Bombay Dyeing Q1 revenue jumps over four-folds to ₹381 cr

Bombay Dyeing, an Indian textile company, has recorded 318 per cent escalation in its revenue to ₹380.8 crore during first quarter (Q1) of FY22 ended on June 30, 2021, against the revenue of ₹91.2 crore in the same period of previous fiscal. However, the company incurred a loss of ₹107.9 crore compared to loss of ₹129.1 crore in Q1 FY21.

 

Bombay Dyeing, an Indian textile company, has recorded 318 per cent escalation in its revenue to ₹380.8 crore during first quarter (Q1) of FY22 ended on June 30, 2021, against the revenue of ₹91.2 crore in the same period of previous fiscal. However, the company incurred a loss of ₹107.9 crore compared to loss of ₹129.1 crore in Q1 FY21. #

Polyester segment sales for the three-month period jumped to ₹324.6 crore (₹77.2 crore), while retail/textile segment reported sales of ₹2.8 crore (₹1.6 crore).

 

Bombay Dyeing, an Indian textile company, has recorded 318 per cent escalation in its revenue to ₹380.8 crore during first quarter (Q1) of FY22 ended on June 30, 2021, against the revenue of ₹91.2 crore in the same period of previous fiscal. However, the company incurred a loss of ₹107.9 crore compared to loss of ₹129.1 crore in Q1 FY21. #

“Covid-19 has impacted business operations of the company, its manufacturing, sales, as also revenue of real estate operations, cashflows, etc. The company has taken into account the possible impact of Covid-19 in preparation of the financial results, including its assessment of going concern assumption and the recoverability of the carrying value of the assets, if any,” the polyester staple fibre manufacturer said in a press release. 

 

Bombay Dyeing, an Indian textile company, has recorded 318 per cent escalation in its revenue to ₹380.8 crore during first quarter (Q1) of FY22 ended on June 30, 2021, against the revenue of ₹91.2 crore in the same period of previous fiscal. However, the company incurred a loss of ₹107.9 crore compared to loss of ₹129.1 crore in Q1 FY21. #

“The full extent to which the pandemic will impact future financial results of the company cannot be reasonably ascertained and will depend on how Covid-19 evolves over a period of time,” the company added.